ARTICLE | Company News
Rexahn, The Ohio State University deal
October 21, 2013 7:00 AM UTC
Rexahn received an exclusive license to lipid-coated albumin nanoparticle (LCAN) drug delivery technology from the university's Ohio State Innovation Foundation. According to Rexahn, preclinical studi...